Suchergebnisse - "Ritonavir"

PubPharm (2.589)

51

Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs : A Case Study of Lopinavir/Ritonavir

enthalten in: Journal of pharmaceutical sciences | 2021

von Saeed, A. | Schmidt, J. | Munasinghe, W. | +4

52

Cellulose derivatives as effective recrystallization inhibitor for ternary ritonavir solid dispersions : In vitro-in vivo evaluation

enthalten in: Carbohydrate polymers | 2021

von Guan, Q. | Ma, Q. | Zhao, Y. | +5

53

Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient : is it time for a priori tacrolimus dosage reduction?

enthalten in: AIDS (London, England) | 2021

von Naccarato, M. | Kwee, F. | Zaltzman, J. | +1

54

Prescribing intranasal steroids in HIV-positive patients : systematic review of the literature

enthalten in: The Journal of laryngology and otology | 2021

von Seymour, N. | Robinson, M. | Richardson, D. | +3

55

The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment

enthalten in: Turkish journal of medical sciences | 2021

von Çınarka, H. | Günlüoğlu, G. | Çörtük, M. | +9

56

The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia

enthalten in: Science translational medicine | 2021

von Caffall, Z. | Wilkes, B. | Hernández-Martinez, R. | +13

CommentIn: Mov Disord. 2022 Jan;37(1):37. - PMID 34816479

57

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Kendall, M. | Lalloo, U. | Fletcher, C. | +5

58

Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

enthalten in: BMC infectious diseases | 2021

von Mulindwa, F. | Castelnuovo, B. | Kirenga, B. | +4

59

Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings

enthalten in: AIDS (London, England) | 2021

von Apornpong, T. | Grinsztejn, B. | Hughes, M. | +23

60

Severe hyperkalaemia due to a potential drug-drug interaction between eplerenone and antiretrovirals in a HIV-positive patient after a myocardial infarction

enthalten in: International journal of STD & AIDS | 2021

von Cordova, E. | Garibaldi, F. | Bono, L. | +1